Molecular Formula: C
26H
34FNO
5 Molecular Weight: 459.550263
InChIKey: SEERZIQQUAZTOL-ANMDKAQQSA-N
On August 8, 2001 the U.S. Food and Drug Administration (FDA) announced that Bayer Pharmaceutical Division voluntarily withdrew Baycol from the U.S. market, due to reports of fatal Rhabdomyolysis, a severe adverse reaction from this cholesterol-lowering (lipid-lowering) product. It has also been withdrawn from the Canadian market.
From: DrugBank